Market revenue in 2023 | USD 38.8 million |
Market revenue in 2030 | USD 71.3 million |
Growth rate | 9.1% (CAGR from 2023 to 2030) |
Largest segment | Phase iii |
Fastest growing segment | Phase I |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Phase I, Phase II, Phase III, Phase IV |
Key market players worldwide | Thermo Fisher Scientific Inc, IQVIA Holdings Inc, Clara Health, Antidote Health, BBK Worldwide, Clariness, Costas Inc, Worldwide Clinical Trials, Veristat, Elligo Health Research |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to clinical trial patient recruitment services market will help companies and investors design strategic landscapes.
Phase iii was the largest segment with a revenue share of 57.47% in 2023. Horizon Databook has segmented the Japan clinical trial patient recruitment services market based on phase i, phase ii, phase iii, phase iv covering the revenue growth of each sub-segment from 2018 to 2030.
Japan has one of the largest pharmaceutical markets in the world, and its growth is contributing to the increase in demand for clinical trials. In addition, the government recently promoted the use of blockchain to manage data from clinical trials of pharmaceuticals and medical devices.
Such government initiatives are likely to have a positive impact on market growth. In recent years, the number of clinical trials in the country significantly decreased. As per Global Data estimates, the global clinical trial activity of Japan was 4.7% in 2022, whereas in 2018, it was 7%.
The decline in the number of clinical trials is due to the introduction of the Clinical Trials Act in 2018, which was passed to prevent misconduct in trials by imposing strict regulations. The reduction in global-scale clinical trial activity in the country is likely to affect its demand for clinical trial patient recruitment services.
Horizon Databook provides a detailed overview of country-level data and insights on the Japan clinical trial patient recruitment services market , including forecasts for subscribers. This country databook contains high-level insights into Japan clinical trial patient recruitment services market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account